Prevention of abdominal wall hematomas in patients receiving low molecular weight heparin therapy
Gerónimo Pardo, M.; Romero Macías, J.R.; Fuster Lluch, O.
Revista Espanola de Anestesiologia y Reanimacion 53(5): 324-5; author reply 325-6
2006
ISSN/ISBN: 0034-9356 PMID: 16827076 Document Number: 596873
Document emailed within 1 workday
Related Documents
García-Jiménez, A.; Alcázar Montero, J.A.; Fernández González, C.J.; Buño Ramiro, B.; Lamas García, F.D.; García de Castro, R.; Merino Rego, M.D. 2005: Massive abdominal wall hematoma and hemperitoneum secondary to subcutaneous infusion of low molecular weight heparin Revista Espanola de Anestesiologia y Reanimacion 52(9): 572-573Leu, J.G.; Liou, H.H.; Wu, S.C.; Yang, W.C.; Huang, T.P.; Wu, S.C. 1998: Low molecular weight heparin in diabetic and nondiabetic hypercholesterolemic patients receiving long-term hemodialysis Journal of the Formosan Medical Association 97(1): 49-54
Mätzsch, T.; Bergqvist, D.; Blomquist, P.; Jiborn, H. 1987: Influence of standard heparin or low molecular weight heparin on healing of abdominal wounds and colonic anastomoses in rats Acta Chirurgica Scandinavica 153(10): 593-598
Levine, M.N.; Planes, A.; Hirsh, J.; Goodyear, M.; Vochelle, N.; Gent, M. 1989: The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement Thrombosis and Haemostasis 62(3): 940-944
Petralia, P.; Kakkar, A.K. 2004: Antithrombotic therapy with low molecular weight heparin in cancer patients European Journal of Medical Research 9(3): 119-124
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Or, R.; Nagler, A.; Shpilberg, O.; Elad, S.; Naparstek, E.; Kapelushnik, J.; Cass, Y.; Gillis, S.; Chetrit, A.; Slavin, S.; Eldor, A. 1996: Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients Transplantation 61(7): 1067-1071
Brunkwall, J.; Mätzsch, T.; Bergqvist, D. 1990: The effect of unfractionated and low-molecular-weight heparin on the release of prostacyclin from the arterial wall Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 1(6): 641-645
Grunebaum, L.; Fricker, J.P.; Wiesel, M.L.; Vergnes, Y.; Kapps, J.; Cazenave, J.P. 1987: Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery Journal des Maladies Vasculaires 12 Suppl B: 102-104
Akanmu, A.S.; Nnodu, O.E.; Giwa, S.O.; Salako, L.A.; Akinsete, I.; Adebule, G.T.; Adekoya-Cole, T.O.; Odunubi, O.O. 2004: Efficacy and safety of enoxaparin, a low molecular weight heparin in the prevention of deep vein thrombosis in Nigerian patients after orthopaedic surgery African Journal of Medicine and Medical Sciences 33(4): 335-340
McLaughlin, J.A.; Paulson, M.M.; Rosenthal, R.E. 1998: Delayed onset of anterior tibial compartment syndrome in a patient receiving low-molecular-weight heparin. A case report Journal of Bone and Joint Surgery. American Volume 80(12): 1789-1790
Hammerstingl, C.; Tripp, C.; Schmidt, H.; von der Recke, G.; Omran, H. 2007: Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry Journal of Heart Valve Disease 16(3): 285-292
Haas, S. 1995: Combination of low molecular weight heparin and dihydroergotamine for prevention of thrombosis Deutsche Medizinische Wochenschrift 120(14): 503
Zidar, J.P. 2000: Prolonged therapy with low-molecular-weight heparin after PCi Journal of Invasive Cardiology 12 Suppl C: 7c
Forbes, C.D. 1989: Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin British Journal of Clinical Practice 43(11): 396-400
Koppenhagen, K.; Tröster, E.; Matthes, M.; Häring, R. 1990: Prevention of thrombosis with low molecular weight heparin as the only substance and/or with DHE: results of clinical studies Langenbecks Archiv für Chirurgie. Supplement Ii Verhandlungen der Deutschen Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 1990: 1163-1166
Yang, Z.; Liu, X.; Dai, S.; Liu, K.; Zhang, Y.; Sun, J.; Yin, X. 2010: Effectiveness of low molecular weight heparin for prevention of deep vein thrombosis after total hip arthroplasty Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24(9): 1058-1061
Iorio, A.; Agnelli, G. 2000: Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis Archives of Internal Medicine 160(15): 2327-2332
Schwarz, B.; Mittelmeier, H. 1988: Initial clinical experiences with low molecular weight heparin in the prevention of thrombosis in orthopedic surgery Aktuelle Traumatologie 18(5): 226-232
Uzan, A.; Clairefond, P.; Mardiguian, J.; Trillou, M.; Le Fur, G.; Mestre, M. 1985: Prevention of experimental thrombosis of the coronary artery, in anesthetized dogs, with a low molecular weight heparin, enoxaparine (PK 10169) Annales Pharmaceutiques Francaises 43(6): 539-546